FPA Medical Management - FPAMQ Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FPA Medical Management - FPAMQ

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas V. Fant who wrote (488)	5/13/1998 4:15:00 PM
From: Alfredo Nova	Read Replies (2) of 1110

To all: I recently became interested in FPAM because of its good reputation and declining stock value. It is a shame that First Boston downgraded the stock, joining the other brokerage houses. Their previous buy rating with a target of 40-45 in 12 mos had my buy some shares at 16.5. I read the company report and it seems that Dr Dresnick should be good for the job. In addition, I don't think Humana would give them 23 center to run if they had no confidence in the new management. We will probably expect a more prudent course, reduction in debt (always a good thing) and hopefully a decent growth. The current low price/sales ratio, even compared to Phycor, should provide decent support for the stock. Just some thought, I don't function too well since I had a tonsillectomy last week and I surely don't wish this to anybody, regards Alfredo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next